FinTech

Page 4

The latest news

An AI-powered dashboard showing automated expense approvals and policy enforcement, symbolizing Ramp’s autonomous finance operations platform.

Ramp AI Agents Save $10B Through Autonomous Finance Ops

Read more
Cash App logo and Bitcoin rising over financial chart with Block branding

Cash App Soars: Block Hits Record Profits on Bitcoin Boom

Read more
Monzo logo on smartphone, FCA document in background symbolizing compliance enforcement

FCA Fines Monzo £21.1 Million for Anti-Money Laundering Failures

Read more
Swissquote and Yuh logos merging digitally on a smartphone screen, symbolizing consolidation of Swiss digital banking platforms

Swissquote Acquires Full Control of Yuh App for CHF 180 Million

Read more
Mobile banking app interface with calming blue-green colors and Starling logo, symbolizing financial wellness and rebranding strategy

Starling Bank Profits Jump 55% to £301 Million, Plans Rebrand

Read more
European Central Bank headquarters with digital euro symbol and climate icons overlaid, illustrating monetary innovation and ecological strategy

Digital Euro and ECB Climate Policy Reshape EU Finance

Read more
Digital dollar stablecoins powering global transactions as banks and payment networks adopt blockchain rails in 2024

Stablecoin Transactions Surpass Visa and Mastercard

Read more

Wise Seeks U.S. Trust Charter to Tap Fed Payment Systems

Read more

Klarna Exclusive BNPL Partner for Bolt’s Merchant Network

Read more

Retail Crypto Investors Underperform Institutions, BIS Finds

Read more

PayPal to Process $697 Million in College Athlete Payments

Read more

FHFA Orders Fannie Mae to Accept Crypto Assets for Mortgages

Read more

HealthTech News

View All
Hims & Hers Health Q2 2026 earnings and financial results, showing the company amid record revenue growth, international expansion following the Eucalyptus acquisition, weight loss and GLP-1 business changes, and mounting legal and regulatory risk from the FTC privacy lawsuit.

Hims & Hers Posts Record Revenue Amid Mounting Legal Risk

Read more
Scientist holding a laboratory test tube during pharmaceutical research at Novo Nordisk, illustrating Ziltivekimab, ZEUS trial, IL-6 inhibitor research, cardiovascular inflammation therapy, heart disease treatment and clinical drug development.

Novo Nordisk's Ziltivekimab Fails Pivotal Heart Trial

Read more
Eli Lilly Q1 2026 results reflecting tirzepatide sales surge, Mounjaro and Zepbound growth, and expanding GLP-1 drug market demand

Eli Lilly Posts 56% Revenue Surge as Incretin Empire Expands

Read more